Sentence examples for baseline tender from inspiring English sources

Patients in remission were younger (P = 0.041) with lower baseline tender joint count (TJC 28 and PGH than those not in remission (P = 0.001, P = 0.047).

However, significant decreases (or trends) over time were observed in baseline swollen joint count (p=0.06, R=0.17; figure 2B) and CRP (p=0.03, R=0.27; figure 2F), but not in baseline tender joint counts (figure 2D).

There were also slight differences in mean baseline tender and swollen joint counts and CRP levels, which were higher in the PREMIER study and considered related to the longer duration of RA at baseline versus the current study.

The mean (SD) number of baseline tender points (pairs) was 8.75 (0.4) in both treatment groups, and 3.25 (2.7) and 8.25 (0.9) in r-hGH and control groups at 12 months, respectively.

In methotrexate-experienced trials, no significant change was observed over the years included in this study in any inclusion criteria (including swollen joint counts and C-reactive protein (CRP)), but a significant decrease over time was observed in the baseline swollen joint count, CRP and total Sharp or van der Heijde modified Sharp score, but not in baseline tender joint counts.

The association between remission and PROs was assessed with and without adjustment for the baseline variables anticitrullinated protein antibody (ACPA) status (positive or negative), sex (male or female), DAS at baseline, tender joint count and swollen joint count which were entered in the model as fixed effects.

At week 16, patients with <20% improvement from baseline in tender and swollen joint counts at week 14 could enter double-blind early escape (EE).

Furthermore, ACR20 non-responders demonstrated > 20% improvements from baseline in tender and swollen joint counts and in physician's global assessment of disease activity.

At week 16, patients in groups 1, 2, or 3 who had less than 20% improvement from baseline in tender and swollen joints entered early escape.

The analyses were also performed with adjustment (adjusted β) for ACPA status (positive or negative), sex (male or female), DAS at baseline and tender and swollen joint counts, and these were also entered into the analysis as fixed variables.

Changes from baseline in tender joint count, swollen joint count, patient's pain assessment, patient's and physician's global assessment, CRP, ESR, HAQ-DI and MAF were compared between treatment groups.